Prevalent Statin Use in Long-Stay Nursing Home Residents with Life-Limiting Illness.

ABSTRACT:

Objectives

To evaluate the prevalence and factors associated with statin pharmacotherapy in long-stay nursing home residents with life-limiting illness.

Design

Cross-sectional.

Setting

US Medicare- and Medicaid-certified nursing home facilities.

Participants

Long-stay nursing home resident Medicare fee-for-service beneficiaries aged 65 years or older with life-limiting illness (n = 424 212).

Measurements

Prevalent statin use was estimated as any low-moderate intensity (daily dose low-density lipoprotein-cholesterol [LDL-C] reduction <30%-50%) and high-intensity (daily dose LDL-C reduction >50%) use via Medicare Part D claims for a prescription supply on September 30, 2016, with a 90-day look-back period. Life-limiting illness was operationally defined to

SUBMITTER: Mack DS 

PROVIDER: S-EPMC8072406 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature